Evaluating genetic screening/counseling for patients diagnosed with prostate cancer who meet hereditary risk assessment based on NCCN Guidelines.

Ruben Ruiz Vega, Andrew Thomas Johnson, Oluseyi Abidoye et al.|Journal of Clinical Oncology|2023

Cited by 0